Back to Search
NORMAN RELKIN, MD
MD
Neurology Physician
NPI: 1871680959Individual
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
186770(NY)
Research & Publications (20)
18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.
PMID 18294736·Neurobiol Aging·2009
3-trial
A large, community-based, open-label trial of donepezil in the treatment of Alzheimer's disease.
PMID 12714795·Dement Geriatr Cogn Disord·2003
3-trial
Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.
PMID 17561789·Expert Rev Neurother·2007
6-review
Disclosure of APOE genotype for risk of Alzheimer's disease.
PMID 19605829·N Engl J Med·2009
4-observational
Features of gait most responsive to tap test in normal pressure hydrocephalus.
PMID 18359152·Clin Neurol Neurosurg·2008
8-other
Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience.
PMID 18344711·Genet Med·2008
4-observational
Cholinergic components of frontal lobe function and dysfunction.
PMID 18631684·Handb Clin Neurol·2008
6-review
Disease-modifying approaches to Alzheimer's disease: challenges and opportunities-Lessons from donepezil therapy.
PMID 18631986·Alzheimers Dement·2008
6-review
8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease.
PMID 17880003·Proteomics·2007
8-other
Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease.
PMID 17167789·Ann Neurol·2007
8-other
Do cholinergic therapies have disease-modifying effects in Alzheimer's disease?
PMID 19595868·Alzheimers Dement·2006
8-other
Proteomic analysis of cerebrospinal fluid changes related to postmortem interval.
PMID 16887899·Clin Chem·2006
8-other
Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL Study.
PMID 17172937·Genet Med·2006
8-other
Alzheimer's disease cerebrospinal fluid biomarker discovery: a proteomics approach.
PMID 16372405·Curr Opin Mol Ther·2005
6-review
Guidelines for management of idiopathic normal pressure hydrocephalus: progress to date.
PMID 16463856·Acta Neurochir Suppl·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 428 E 72ND ST OFC 500
NEW YORK, NY 10021 - Phone
- (212) 746-2441
Quick Facts
- NPI
- 1871680959
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile